or Try an Advanced Search...

    Technical Analysis for NYR - Nyrada Inc.

    Grade Last Price % Change Price Change
    B 0.105 5.00% 0.005
    NYR closed unchanged on Monday, November 25, 2024, on 23 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical NYR trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 5.00%
    Gapped Up Strength 5.00%
    Oversold Stochastic Weakness 5.00%
    MACD Bearish Centerline Cross Bearish 5.00%
    Narrow Range Bar Range Contraction 5.00%
    Doji - Bullish? Reversal 5.00%
    Gapped Down Weakness 5.00%
    Oversold Stochastic Weakness 5.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for NYR ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 37 minutes ago
    Rose Above Previous Day's High about 2 hours ago
    Rose Above 20 DMA about 2 hours ago
    Up 1 ATR about 2 hours ago
    Up 5% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NYR Chart by TradingView
    Basic chart:

    Profile

    Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Diseases Drugs Drug Development

    Is NYR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.17
    52 Week Low 0.018
    Average Volume 1,056,467
    200-Day Moving Average 0.074
    50-Day Moving Average 0.099
    20-Day Moving Average 0.110
    10-Day Moving Average 0.105
    Average True Range 0.007
    RSI (14) 45.05
    ADX 15.73
    +DI 28.708
    -DI 27.177
    Chandelier Exit (Long, 3 ATRs) 0.133
    Chandelier Exit (Short, 3 ATRs) 0.122
    Upper Bollinger Bands 0.125
    Lower Bollinger Band 0.095
    Percent B (%b) 0.16
    BandWidth 26.909
    MACD Line -0.001
    MACD Signal Line 0.002
    MACD Histogram -0.0025
    Fundamentals Value
    Market Cap 10.95 Million
    Num Shares 109 Million
    EPS -99999.99
    Price-to-Earnings (P/E) Ratio 0.00
    Price-to-Sales 0.00
    Price-to-Book 4.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.108
    Resistance 3 (R3) 0.108 0.107 0.106
    Resistance 2 (R2) 0.107 0.105 0.106 0.106
    Resistance 1 (R1) 0.103 0.104 0.103 0.103 0.105
    Pivot Point 0.102 0.102 0.101 0.101 0.102
    Support 1 (S1) 0.098 0.100 0.098 0.098 0.095
    Support 2 (S2) 0.097 0.099 0.096 0.094
    Support 3 (S3) 0.093 0.097 0.094
    Support 4 (S4) 0.093